Next, we checked the putative copy number alteration and mRNA expression of PIK3C2B from GISTIC software and found a significant trend of PIK3C2B gain and amplification in ovarian cancer patients (Figure 1G,H). This evidence concerns the gene PIK3C2B and ovarian cancer.